Efficacy of dalfampridine in neuromyelitis optica spectrum disorder: A pilot study.

Jérôme de SèzeChristine ClercMatthieu BéreauBertrand BourreHélène ZephirNicolas CollonguesLaurent KremerPatrick VermerschKévin Bigaut

Published in: Multiple sclerosis journal - experimental, translational and clinical (2024)

Dalfampridine seems to be useful for symptomatic treatment of walking impairment in neuromyelitis optica spectrum disorder.

Keyphrases